← SynDRA
CANDESARTAN
SynDRA canonical compound SYN0003163 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | AGTR1 |
| Mechanism of action | Angiotensin receptor antagonist |
| Indication | congestive heart failure | hypertension |
| Disease area | cardiology |
All known targets
Mechanisms of action (all sources)
- Angiotensin receptor antagonist
- AGTR1 ANTAGONIST
Cross-references
Synonyms
- Blopress
- Candemore
- CV-11974
- NSC-759858
- Candesartan cilexetil related compound g
- Ratacand
- CV 11974
- 1-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylic acid
- UNII-S8Q36MD2XX
- 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid
- CHEMBL1016
- S8Q36MD2XX
- 2-Ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid
- CHEBI:3347
- C24H20N6O3
- 2-ethoxy-3-[[4-[2-(1h-tetrazol-5-yl)phenyl]phenyl]methyl]-3h-benzoimidazole-4-carboxylic acid
- NCGC00167474-01
- AK-57139
- Candesartan [BAN]
- CV11974
- Amias (TN)
- Atacand (TN)
- Blopress (TN)
- Candesartan [USAN:INN]
- KS-5003
- Ratacand (TN)
- Candesartan (USAN/INN)
- Atacand, Blopress, Amias, Ratacand,Candesartan
- 2-(ethyloxy)-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid
- 2-Ethoxy-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl] methyl]-3H-benzoimidazole-4-carboxylic acid
- 2-ethoxy-1-({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl)-1H-benzimidazole-7-carboxylic acid
- 2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid
- 2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl}-1H-benzimidazole-7-carboxylic acid
- 2-ethoxy-7-carboxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methylbenzimidazole
- [3H]candesartan
- blopress
- candesartan cilexetil impurity g (ep impurity)
- candesartan cilexetil related compound g
Look up CANDESARTAN in the interactive SynDRA portal →